// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Exercise training and airway inflammation in severe-asthma: results from a feasibility study

Sally Majd - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Does body mass index influence survival of patients with idiopathic pulmonary fibrosis?

Nesrin Mogulkoc - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Improving Paediatric asthma care - a one stop nurse led approach

Sally Hails - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD

Mona Bafadhel - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Budesonide

Multidisciplinary approach to connective tissue disease (CTD) related pleural effusions

Hugh Ip - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

28-day post-operative complications in elective bariatric patients with obstructive sleep apnoea

Peter Siu Pan Cho - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Disclosure of smoking in adolescents: a feasibility study

Colette Datt - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Development of a new calcilytic for the treatment of inflammatory lung disease

Polina Yarova - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Arginine hydrochloride

Validation of a macrophage specific cell line for the development of an in vitro lower airways co-culture model

Abigail Martin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Phorbol myristate acetate

Genome-wide interaction study of environmental tobacco smoke exposure on time-to-asthma onset in childhood

Pierre-Emmanuel Sugier - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Assessment of Signal Integrity in Paediatric Cardiorespiratory Sleep Studies

Ansel Godinho - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Adolescent smoking by parents and asthma in their children:repeat cross-sectional surveys in England

James Potts - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Effect of Pulmonary Rehabilitation on physical and mental status in cognitively impaired patients with COPD

Vasileios Andrianopoulos - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

No clinically relevant hypersensitivity reactions in clinical trials with tralokinumab in asthma

Mats Carlsson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

CAT-354

Weighted Gene Co-expression Network Analysis of blood paediatric samples from the U-BIOPRED study identifies oxidative stress association with asthma severity

Stelios Pavlidis - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Different relation between exhaled nitric oxide and lung function with regard to current smoking

Elisabet Nerpin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Bronchiectasis Quality Improvement Project

Alice Gray - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of functional residual capacity (FRC) measured by plethysmography (FRCpleth) and multiple breath washout (FRCmbw) in schoolchildren with cystic fibrosis (CF).

Mollie Riley - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Respiratory viral point of care testing (POCT) allows improved infection control and bed management during an influenza outbreak

Kay Roy - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Influenza

N/A

Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation

Joanne Kelly - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved